NIH-funded research R03 grant

Investigating the link between non-alcoholic fatty liver disease and kidney stone risk

Official title: Non-alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis

Funded at University of Alabama at Birmingham · NIH-11042802 · Data updated 2026-11-12

This study is looking at how having non-alcoholic fatty liver disease might raise the chances of getting kidney stones, and it’s for people with this liver condition who can help by sharing some samples for research.

More Fatty Liver research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startMarch 1, 2024
Project endJanuary 31, 2026
Funding year2025
Award (this year)$111,375
NIH project number5R03DK139235-02
Project IDNIH-11042802 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals aged 21 and older who have been diagnosed with non-alcoholic fatty liver disease and may also be at risk for kidney stones.

Less likely to help

Patients without non-alcoholic fatty liver disease or those who do not have a history of kidney stones may not benefit from this research.

What this research studies

This research explores how non-alcoholic fatty liver disease (NAFLD) may increase the risk of developing kidney stones through the synthesis of oxalate in the body. It focuses on understanding the metabolic processes involved, particularly how ascorbic acid and glyoxylate contribute to oxalate production. By examining liver biopsies and urine samples from affected individuals, the study aims to identify potential biomarkers and mechanisms that link NAFLD with kidney stone formation. Patients may be asked to provide samples and participate in assessments to help clarify these relationships.

Why it matters

Potential benefit: If successful, this research could lead to better prevention strategies for kidney stones in patients with non-alcoholic fatty liver disease.

How similar studies have gone: Previous studies have indicated a connection between metabolic disorders and kidney stone risk, suggesting that this research could build on established findings.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Wood, Kyle D — University of Alabama at Birmingham
  • Study coordinator: Wood, Kyle D

Related research

Other NIH-funded projects on the same topics.

  • Role of fat droplets in liver fat and inflammatory signals in NAFLD

    A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11623263

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

  • How the TET1 gene affects non-alcoholic fatty liver disease

    Researchers are looking at whether changes in the TET1 gene and DNA 'tagging' (methylation) play a role in adult non-alcoholic fatty liver disease.

    NIH research State University New York Stony Brook · Stony Brook, United States · NIH-11447065

  • Hepatocellular Genetic Clues for Fatty Liver in Hispanic Adults

    A large NIH grant helps researchers study why fatty liver develops in Hispanic adults and how genetics interact with lifestyle to affect risk.

    NIH research University of Texas Rio Grande Valley · Edinburg, United States · NIH-11421441

  • Toxic fats, vitamin B12 loss, and AHR may drive fatty liver disease

    This grant looks at how certain environmental chemicals may trigger liver damage linked to fatty liver disease and how a vitamin found in the blood could be affected.

    NIH research Michigan State University · East Lansing, United States · NIH-11398883

  • Glutamine and T cells in fatty liver disease

    A study explores how liver glutamine levels affect inflammatory CD4+ T cells in fatty liver disease to find potential new ways to reduce liver inflammation.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11388863

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.